Neogenomics (NEO) Convertible Debt (2020 - 2026)

Neogenomics has reported Convertible Debt for 7 years, with the latest figure at $342.2 million in Q1 2026.

• For the quarter ending Q1 2026, Convertible Debt changed 0.45% year-over-year to $342.2 million; the trailing twelve-month figure through Mar 2026 stood at $342.2 million (changed 0.45% YoY), and the FY2025 full-year result was $341.9 million, changed 0.45% from the prior year.
• Convertible Debt for Q1 2026 stood at $342.2 million, roughly flat from $341.9 million in the prior quarter.
• The five-year high for Convertible Debt was $538.9 million in Q1 2024, with the low at $339.6 million in Q2 2024.
• Historically, Convertible Debt has averaged $444.2 million across 5 years, with a median of $533.2 million in 2022.
• Annual changes were most pronounced in 2024 — Convertible Debt advanced 0.54% — and 2025, when it plunged 36.78%.
• Neogenomics' Convertible Debt stood at $535.3 million in 2022, then grew by 0.54% to $538.2 million in 2023, then sank by 36.76% to $340.3 million in 2024, then gained by 0.45% to $341.9 million in 2025, then increased by 0.11% to $342.2 million in 2026.
• The last three Convertible Debt figures came in at $342.2 million (Q1 2026), $341.9 million (Q4 2025), and $341.5 million (Q3 2025), per Business Quant data.